As most manufacturers experienced firsthand, operating during a pandemic is challenging. Pfizer manufactures more than 23 billion doses of biopharmaceutical products – ranging from solid oral doses to vaccines and sterile injectables – across a network of 42 global manufacturing sites. Accomplishing this task during a pandemic intensified the […]

Click here to view original web page at

This website uses cookies and asks your personal data to enhance your browsing experience. We are committed to protecting your privacy and ensuring your data is handled in compliance with the General Data Protection Regulation (GDPR).